Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Olfactory transduction | R-HSA-9751605 | map04740 | sparteine | 644020 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | sparteine | 644020 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sparteine | 644020 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | sparteine | 644020 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | sparteine | 644020 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | sparteine | 644020 | drug-path |
| Nucleotide excision repair | R-HSA-5696398 | map03420 | sparteine | 644020 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sparteine | 644020 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | sparteine | 644020 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | sparteine | 644020 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | sparteine | 644020 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | sparteine | 644020 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | salsolinol | 9687 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | salsolinol | 9687 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | salsolinol | 9687 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | salsolinol | 9687 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | salsolinol | 9687 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | salsolinol | 9687 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | salsolinol | 9687 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | salsolinol | 9687 | drug-path |